# FDA Inspection 987218 - BHP Holdings Inc - September 30, 2016

Source: https://www.keypedia.com/records/fda_inspections/bhp-holdings-inc/15ad6c64-8f7a-4471-9002-3afc447a7f32
Source feed: FDA_Inspections

> FDA Inspection 987218 for BHP Holdings Inc on September 30, 2016. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 987218
- Company Name: BHP Holdings Inc
- Inspection Date: 2016-09-30
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Unapproved and Misbranded Drugs
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1228088 - 2024-01-17](https://www.keypedia.com/records/fda_inspections/bhp-holdings-inc/b7b70598-82fc-478d-9b77-2095ef2ad84f)
- [FDA Inspection 1150452 - 2021-05-25](https://www.keypedia.com/records/fda_inspections/bhp-holdings-inc/fa4b2c65-e676-4a9d-8f3f-e8e7f92bcd85)
- [FDA Inspection 1150452 - 2021-05-25](https://www.keypedia.com/records/fda_inspections/bhp-holdings-inc/26aa32c7-e42e-4f05-a7ab-e19c3ec20954)
- [FDA Inspection 1109472 - 2019-11-08](https://www.keypedia.com/records/fda_inspections/bhp-holdings-inc/5cc17fcb-7436-47ef-886d-b36b3ae44cb1)
- [FDA Inspection 1109472 - 2019-11-08](https://www.keypedia.com/records/fda_inspections/bhp-holdings-inc/ee2837f8-168c-4b92-9252-c229676dbbcb)

Company: https://www.keypedia.com/companies/bhp-holdings-inc/32c91216-0ca6-4ced-8856-11d4ad82489a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c